Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07694817Not Yet Recruiting

Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases

NCT05461469Completed

CDL Validation Study

Showing all 2 trials

Research Network

Active Sponsors

  • University Clinic for Ophthalmology and Optometry- Salzburg1
  • IRCCS San Raffaele1
  • Occyo GmbH1

Related Conditions

  • Cornea Disease2
  • Limbal Stemcell Deficiency1
  • Neurotrophic Keratopathy1
  • Chronic Conjunctivitis Of Both Eyes1
  • Limbal Stem Cell Deficiency Lscd1

Activity Timeline